Melanotan I and Melanotan II are both analogs of alpha-MSH, and the numbering suggests a simple generational upgrade. The published pharmacology describes something different: the two differ in which melanocortin receptors they engage, and that difference is the reason they appear in separate research literatures.
- Melanotan I
- MC1R-selective analog
- Melanotan II
- Non-selective melanocortin agonist
- Shared family
- Alpha-MSH analogs
- Key difference
- Receptor selectivity
The short answer
Melanotan I is selective for the MC1R melanocortin receptor. Melanotan II is a non-selective melanocortin agonist – it engages MC1R but also other melanocortin receptors including MC3R and MC4R. Melanotan II is not a newer or improved Melanotan I; it is a structurally different, shorter cyclic analog with a broader receptor profile.
| Melanotan I | Melanotan II | |
|---|---|---|
| Receptor profile | MC1R-selective | Non-selective (MC1R, MC3R, MC4R) |
| Structure | Linear analog | Shorter cyclic analog |
| Family | Alpha-MSH analog | Alpha-MSH analog |
| Research breadth | Narrower – MC1R pathway | Broader, multiple receptors |
| Related compound | – | PT-141 is a Melanotan II derivative |
Why selectivity matters in research
Melanocortin receptors are a family, and the different members are expressed in different tissues and coupled to different downstream pathways. A compound selective for one receptor produces a narrower set of observable effects in a study; a non-selective agonist engages several pathways at once, which makes attributing an observation to a specific receptor harder.
That is a methodological point rather than a safety ranking: for a research design aiming to isolate MC1R signalling, a selective compound and a non-selective one are not interchangeable tools.
The PT-141 connection
PT-141 is a derivative of Melanotan II and appears in a separate research literature again, focused on different melanocortin receptor activity. Its existence illustrates the point: within one compound family, receptor selectivity is the axis along which the research separates.
Evidence and handling
Both are supplied as lyophilized powders and reconstituted with bacteriostatic water, stored cold and dark. Published human data for both is limited relative to their visibility, and much of the available literature is mechanistic. Non-selective receptor engagement means a broader range of observed effects in study models, which is a reason to read the Melanotan II literature carefully rather than a reason to assume equivalence with Melanotan I.
All compounds referenced here are supplied as analytical-grade reference materials for in-vitro and laboratory research only. Nothing on this page is a recommendation for human or veterinary use, and no comparison below should be read as ranking these materials for any personal outcome.
Studies cited
- Afamelanotide — overview (, 2012)
- Melanocortin system and metabolic disorders (Nature reviews. Endocrinology, 2023)
- Afamelanotide in skin disease — review (Postepy dermatologii i alergologii, 2024)
- Melanotan II — melanogenesis & skin pigmentation (phase I) (Life Sciences, 1996)
- Melanotan II and thermogenesis — mouse model (Experimental physiology, 2021)
- Melanotan II and feeding behavior — brain study (Neuropeptides, 2022)
Questions
What is the difference between Melanotan I and Melanotan II?
Melanotan I is selective for the MC1R melanocortin receptor. Melanotan II is non-selective and engages several melanocortin receptors including MC3R and MC4R. They are structurally different analogs, not two generations of the same molecule.
Is Melanotan II a newer version of Melanotan I?
No. Melanotan II is a shorter cyclic analog with a broader receptor profile, not an improved or later version of Melanotan I. The numbering does not indicate a generational upgrade.
Is PT-141 related to Melanotan II?
PT-141 is a derivative of Melanotan II. It appears in its own research literature focused on different melanocortin receptor activity.
Why does receptor selectivity matter for research?
Melanocortin receptors are a family expressed in different tissues with different downstream pathways. A selective compound engages one, making observations easier to attribute; a non-selective agonist engages several at once, which complicates isolating any single receptor's contribution.
For laboratory research and educational purposes only. Not medical advice. The materials discussed are not for human or animal consumption and have not been evaluated by the FDA.